Hoffman's Wild Ride: Passed Over by Orioles & Braves, Lands $33M with Blue Jays 

Jeff Hoffman’s journey to the Blue Jays raises some eyebrows. Two teams back out due to shoulder concerns, yet Toronto invests $33 million? Are the Orioles and Braves overly cautious, or are the Blue Jays taking a gamble? Hoffman claims he’s healthy, but his injury history suggests otherwise. What do you make of this signing? Is this a shrewd move by the Jays, or a potential disaster waiting to happen? Where do you see Hoffman fitting into their bullpen? Given his playoff struggles last year, can he be relied upon in high-pressure situations? Let’s hear your thoughts. Is Hoffman worth the risk? Furthermore, does this signing impact other free agent relievers and how teams approach medical evaluations? Could this set a precedent? This situation opens a Pandora's Box of questions, let’s discuss!